What is the price target for MOR stock?
12 analysts have analysed MOR.DE and the average price target is 55.59 EUR. This implies a price decrease of -17.34% is expected in the next year compared to the current price of 67.25.
MORPHOSYS AG (MOR.DE) Forecast, Price Target & Analyst Ratings
FRA:MOR • DE0006632003
Current stock price
67.25 EUR
-0.45 (-0.66%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MORPHOSYS AG (MOR.DE).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Aug 29, 2024
- Period
- Q2 / 2024
- EPS Estimate
- -€1.15
- Revenue Estimate
- 45.588M
Price Target Details & History
Consensus Price Target and Range
Mean target
€55.59
Upside
-17.34%
From current price of €67.25 to mean target of €55.59, Based on 12 analyst forecasts
Low
€17.17
Median
€69.36
High
€71.40
Price Target Revisions
1 Month
-2.68%
3 Months
-2.68%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for MOR.DE. The average price target is 55.59 EUR. This implies a price decrease of -17.34% is expected in the next year compared to the current price of 67.25.
The average price target has been revised downward by 2.68% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
70.00%
MOR.DE was analyzed by 12 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about MOR.DE.
In the previous month the buy percentage consensus was at a similar level.
MOR.DE was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-25 | Deutsche Bank Capital | Initiate | |
| 2022-11-21 | JP Morgan & Company | Initiate | |
| 2022-10-24 | Deutsche Bank Capital | Initiate | |
| 2022-08-10 | JP Morgan & Company | Initiate | |
| 2022-06-10 | Goldman Sachs | Initiate | |
| 2022-05-11 | JP Morgan & Company | Initiate | |
| 2022-03-24 | Berenberg Capital Markets | Initiate | |
| 2022-03-22 | Deutsche Bank Capital | Initiate | |
| 2022-03-17 | JP Morgan & Company | Initiate | |
| 2022-01-31 | Barclays | Initiate | |
| 2022-01-04 | JP Morgan | Initiate | |
| 2021-11-12 | Morgan Stanley | Initiate | |
| 2021-11-01 | JP Morgan | Initiate | |
| 2021-09-17 | Morgan Stanley | Initiate | |
| 2021-09-13 | Goldman Sachs | Initiate | |
| 2021-09-02 | Barclays | Initiate | |
| 2021-08-06 | Deutsche Bank | Initiate | |
| 2021-08-04 | JPMorgan Chase | Initiate | |
| 2021-07-29 | Berenberg Bank | Initiate | |
| 2021-07-19 | Barclays | Initiate | |
| 2021-07-10 | Morgan Stanley | Initiate | |
| 2021-07-09 | Morgan Stanley | Initiate | |
| 2021-07-05 | Stifel Nicolaus | Initiate | |
| 2021-06-16 | Berenberg Bank | Initiate | Buy |
| 2021-06-14 | JPMorgan Chase | Initiate | Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 29, 2024
- Period
- Q2 / 2024
- EPS Estimate
- -€1.15
- Revenue Estimate
- 45.588M
- Revenue Q2Q
- -14.25%
- EPS Q2Q
- 46.98%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.71%
EPS (1 Month)
3.95%
EPS (3 Months)
9.81%
Next Earnings Summary
MOR.DE is expected to report earnings on 8/29/2024. The consensus EPS estimate for the next earnings is -1.15 EUR and the consensus revenue estimate is 45.59M EUR.
The next earnings revenue estimate has been revised upward by 0.71% in the past 3 months.
Full Analyst Estimates 2024 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 179.612M -45.19% | 278.267M 54.93% | 238.278M -14.37% | 234.49M -1.59% | 307.62M 31.19% | 449.11M 46.00% | 730.22M 62.59% | 1.027B 40.64% | 920.9M -10.33% | 1.063B 15.43% | |
| EBITDA YoY % growth | -265.863M -1,229.09% | -201.918M 24.05% | -222.37M -10.13% | -158.451M 28.74% | -84.843M 46.45% | 2.134M 102.52% | -6.199M -390.48% | N/A | N/A | N/A | |
| EBIT YoY % growth | -275.954M -1,913.43% | -212.454M 23.01% | -232.905M -9.63% | -190.346M 18.27% | -112.088M 41.11% | -16.182M 85.56% | 289.88M 1,891.40% | 411.77M 42.05% | -95.613M -123.22% | -34.219M 64.21% | |
| Operating Margin | -153.64% | -76.35% | -97.75% | -81.17% | -36.44% | -3.60% | 39.70% | 40.09% | -10.38% | -3.22% | |
| EPS YoY % growth | -15.40 -873.87% | -4.42 71.30% | -5.53 -25.11% | -4.38 20.86% | -3.35 23.51% | -1.19 64.40% | -1.49 -24.65% | 4.94 432.28% | 3.68 -25.36% | 5.23 42.08% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -1.15 46.98% | -1.02 70.86% | -0.98 -167.91% | -0.67 91.83% |
| Revenue Q2Q % growth | 45.588M -14.25% | 47.304M -25.83% | 48.73M -17.43% | 36.287M 31.77% |
| EBITDA Q2Q % growth | -12.666M 71.68% | -15.696M 55.24% | -20.746M 71.11% | N/A |
| EBIT Q2Q % growth | -29.019M 42.51% | -27.249M 37.42% | -26.161M 68.23% | -29.517M 88.82% |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.29%
EPS Next 5 Year
23.67%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
22.79%
Revenue Next 5 Year
33.46%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
26.15%
EBIT Next 5 Year
18.59%
MORPHOSYS AG / MOR.DE Forecast FAQ
When does MORPHOSYS AG (MOR.DE) report earnings?
MORPHOSYS AG (MOR.DE) will report earnings on 2024-08-29, after the market close.
What are the consensus estimates for MORPHOSYS AG (MOR.DE) next earnings?
The consensus EPS estimate for the next earnings of MORPHOSYS AG (MOR.DE) is -1.15 EUR and the consensus revenue estimate is 45.59M EUR.
What is the consensus rating for MORPHOSYS AG (MOR.DE) stock?
The consensus rating for MORPHOSYS AG (MOR.DE) is 70 / 100 . This indicates that analysts generally have a neutral outlook on the stock.